✦ LIBER ✦

Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571

✍ Scribed by Wang, Wen-Lan; Healy, Mary Ellen; Sattler, Martin; Verma, Shalini; Lin, Jeffrey; Maulik, Gautam; Stiles, Charles D; Griffin, James D; Johnson, Bruce E; Salgia, Ravi

Book ID: 110064019
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 295 KB
Volume: 19
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1203698

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of the tyrosine kinase inhibit

Influence of the tyrosine kinase inhibitors STI571 (Glivec®), lavendustin A and genistein on human mast cell line (HMC-1560) activation

✍ Kristin Löber; Amparo Alfonso; Luis Escribano; Luis M. Botana 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 1 views

## Abstract The human mast cell line (HMC‐1^560^) was used to study the effects of tyrosine kinase (TyrK) inhibition on histamine release in consequence of intracellular Ca^2+^ or pH changes. This is important since the TyrK inhibitor STI571 (Glivec®) inhibits proliferation and induces apoptosis in

Genistein enhances the effect of epiderm

Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines

✍ Shirish M. Gadgeel; Shadan Ali; Philip A. Philip; Antoinette Wozniak; Fazlul H. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 782 KB

Epidermal growth factor receptor tyrosin

Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues

✍ K. Bencardino; M. Manzoni; S. Delfanti; A. Riccardi; M. Danova; G. R. Corazza 📂 Article 📅 2007 🏛 Springer Milan 🌐 English ⚖ 117 KB

Inhibition of transforming growth factor

Inhibition of transforming growth factor α (TGF-α)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868

✍ Simpson, B J B; Rabiasz, G; Gordge, P; Smyth, J; Langdon, S P 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 191 KB

Sequence dependence of cell growth inhib

Sequence dependence of cell growth inhibition by EGFR–tyrosine kinase inhibitor ZD1839, docetaxel, and cisplatin in head and neck cancer

✍ Carmen M. Klass; Mi Sun Choe; Selwyn J. Hurwitz; Mourad Tighiouart; Xin Zhang; Z 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB

## Abstract ## Background This study was to explore whether the efficacy of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (Z, Iressa, gefitinib) plus chemotherapeutic agents docetaxel (D) and cisplatin (P) may benefit from sequencing of the combination. ## Methods

The Potential Clinical and Economic Outc

The Potential Clinical and Economic Outcomes of Pharmacogenomic Approaches to EGFR-Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Cancer

✍ Josh J. Carlson; Louis P. Garrison; Scott D. Ramsey; David L. Veenstra 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB